Janux Therapeutics, Inc. (JANX) vs Latigo Biotherapeutics Inc. (LTGO)

A side-by-side comparison of Janux Therapeutics, Inc. and Latigo Biotherapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

JANX

Janux Therapeutics, Inc.

$998M

$16.37HealthcareDelayed quote: Oct 6, 2026, 10:50 AM EDT

LTGO

Latigo Biotherapeutics Inc.

$997M

$16.58HealthcareDelayed quote: Oct 6, 2026, 10:50 AM EDT

Total return — JANX vs LTGO

growth of $100 · dividends reinvested · last 1y

JANX +3.4% (+3.4%/yr)LTGO -7.6% (-7.6%/yr)JANX compounded faster over this window

JANX LTGO

Metrics side by side

Total return (annualized)

Metric	JANX	LTGO
Total return (1Y)	-30.96%	N/A
Total return CAGR (3Y)	17.29%	N/A
Total return CAGR (5Y)	-6.45%	N/A

LTGO is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full JANX analysis Full LTGO analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.